Liisa Bayko Analyst PerformanceManaging Director at EvercoreLiisa Bayko is a stock analyst at Evercore in the medical sector, covering 17 publicly traded companies. Over the past year, Liisa Bayko has issued 5 stock ratings, including buy and hold recommendations. While full access to Liisa Bayko's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Liisa Bayko's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings32 Last 10 YearsBuy Recommendations87.50% 28 Buy RatingsCompanies Covered17 Unique Companies Ratings Distribution32RatingsDistribution of strong buy, buy, hold, and sell ratings by Liisa Bayko.RatingPercentageCount Strong Buy0.0%0 ratings Buy87.5%28 ratings Hold6.3%2 ratings Sell6.3%2 ratingsOut of 32 total stock ratings issued by Liisa Bayko at Evercore, the majority (87.5%) have been Buy recommendations, followed by 6.3% Hold and 6.3% Sell.Best & Worst CallsBest Call0000.0%CRBPMar 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%HRTXSep 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ17 companiesLiisa Bayko, an analyst at Evercore, currently covers 17 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical17 companies100.0%Liisa Bayko of Evercore specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE9 companies52.9%MED - DRUGS5 companies29.4%PHARMACEUTICAL PREPARATIONS2 companies11.8%BIOTECHNOLOGY1 company5.9% Liisa Bayko's Ratings History at Evercore Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsVRTXVertex Pharmaceuticals1/23/2026Boost Price Target$467.35$530.00Outperform$0.0000.00% ROIENTAEnanta Pharmaceuticals9/15/2025Lower Price Target$7.84$12.00Outperform$0.0000.00% ROIVRTXVertex Pharmaceuticals9/11/2025Lower Price Target$390.80$475.00Outperform$0.0000.00% ROIALNYAlnylam Pharmaceuticals9/11/2025Boost Price Target$468.51$515.05Outperform$0.0000.00% ROISVRASavara5/28/2025Lower Price Target$2.09$2.00In-Line$0.0000.00% ROICRSPCRISPR Therapeutics2/14/2025Upgrade$43.49$99.00Outperform$00.0000.00% ROITVTXTravere Therapeutics2/12/2025Boost Price Target$24.01$45.00Outperform$00.0000.00% ROIBCRXBioCryst Pharmaceuticals1/13/2025Boost Price Target$7.63$12.00Outperform$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
